المؤلفون: Villasboas, J. C.^Aff2, Nowakowski, Grzegorz S.^Aff2

المساهمون: Fowler, Nathan H., editor^Aff1

المصدر: Follicular Lymphoma : Current Management and Novel Approaches. :189-206

المؤلفون: Shah NN, Sokol L

المصدر: ImmunoTargets and Therapy, Vol Volume 10, Pp 225-236 (2021)

مصطلحات موضوعية: cd22, epratuzumab, inotuzumab ozogamicin, bispecific antibody, chimeric antigen receptor, lymphoma, acute lymphoblastic leukemia, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://www.dovepress.com/targeting-cd22-for-the-treatment-of-b-cell-malignancies-peer-reviewed-fulltext-article-ITT; https://doaj.org/toc/2253-1556

URL الوصول: https://doaj.org/article/4c7825745919431bb03dcc5e62b8d1cc

المؤلفون: John A. Reynolds, Jennifer Prattley, Nophar Geifman, Mark Lunt, Caroline Gordon, Ian N. Bruce, on behalf of the MASTERPLANS Consortium

المصدر: Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)

مصطلحات موضوعية: Systemic lupus erythematosus, Disease activity, Trajectory modelling clinical trials, Epratuzumab, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1478-6362

URL الوصول: https://doaj.org/article/7b076ac86d794548ad060875f096af9b

المؤلفون: Bag-Ozbek A, Hui-Yuen JS

المصدر: Therapeutics and Clinical Risk Management, Vol Volume 17, Pp 39-54 (2021)

مصطلحات موضوعية: systemic lupus erythematosus, treatment, novel b cell therapies, belimumab, rituximab, epratuzumab, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/emerging-b-cell-therapies-in-systemic-lupus-erythematosus-peer-reviewed-article-TCRM; https://doaj.org/toc/1178-203X

URL الوصول: https://doaj.org/article/0f39e0e280bd46ca8abcec20e52204ff

المؤلفون: Yoshio, Taku^Aff2, Okamoto, Hiroshi^Aff3

المساهمون: Hirohata, Shunsei, editor^Aff1

المصدر: Neuropsychiatric Systemic Lupus Erythematosus : Pathogenesis, Clinical Aspects and Treatment. :155-168

المؤلفون: Strand, Vibeke, Petri, Michelle, Kalunian, Kenneth, Gordon, Caroline, Wallace, Daniel J, Hobbs, Kathryn, Kelley, Lexy, Kilgallen, Brian, Wegener, William A, Goldenberg, David M

المصدر: Rheumatology. 53(3)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Clinical Trials and Supportive Activities, Clinical Research, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Adolescent, Adrenal Cortex Hormones, Adult, Antibodies, Monoclonal, Humanized, Arthralgia, Dose-Response Relationship, Drug, Female, Humans, Internationality, Lupus Erythematosus, Systemic, Male, Middle Aged, Pain Measurement, Quality of Life, Severity of Illness Index, Treatment Outcome, Young Adult, epratuzumab, CD22, ALLEVIATE, lupus, SLE, HRQOL, SF-36, corticosteroids, clinical trial, monoclonal antibody, Immunology, Public Health and Health Services, Arthritis & Rheumatology, Clinical sciences

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/8dt7m84k

المؤلفون: Lubomir Sokol, Nikesh N. Shah

المصدر: ImmunoTargets and Therapy

مصطلحات موضوعية: medicine.drug_class, Immunology, lymphoma, Review, epratuzumab, acute lymphoblastic leukemia, inotuzumab ozogamicin, Monoclonal antibody, CD19, immune system diseases, hemic and lymphatic diseases, medicine, Immunology and Allergy, CD22, B cell, CD20, chimeric antigen receptor, biology, business.industry, medicine.disease, Chimeric antigen receptor, Lymphoma, bispecific antibody, medicine.anatomical_structure, biology.protein, Cancer research, business, Epratuzumab, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33aded22a97dcbab2bc690f14dbb72d9
https://doi.org/10.2147/itt.s288546

المؤلفون: Joyce S Hui-Yuen, Ayse Bag-Ozbek

المصدر: Therapeutics and Clinical Risk Management

مصطلحات موضوعية: Review, epratuzumab, 030204 cardiovascular system & hematology, Ofatumumab, Atacicept, 03 medical and health sciences, chemistry.chemical_compound, rituximab, 0302 clinical medicine, systemic lupus erythematosus, Blisibimod, immune system diseases, medicine, Pharmacology (medical), 030212 general & internal medicine, General Pharmacology, Toxicology and Pharmaceutics, skin and connective tissue diseases, Chemical Health and Safety, treatment, business.industry, General Medicine, medicine.disease, Belimumab, Tabalumab, chemistry, Immunology, Rituximab, Ocrelizumab, novel B-cell therapies, belimumab, business, Safety Research, Epratuzumab, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c20f95497b95456683c6fd090e6ea0
https://doi.org/10.2147/tcrm.s252592

المؤلفون: Vasekar, Monali^Aff00161, Allen, Joshua E.^Aff00161, Joudeh, Jamal^Aff00162, Claxton, David^Aff00161

المساهمون: El-Deiry, Wafik S, editor^AffID1

المصدر: Impact of Genetic Targets on Cancer Therapy. 779:341-358

Degree: M.D.

المؤلفون: R. Slezák, Z. Janovská, I. Lindrová, V. Radochová

المصدر: Česká Stomatologie a Praktické Zubní Lékařství, Vol 115, Iss 3, Pp 27-33 (2015)

مصطلحات موضوعية: aciclovir, cortisol, labial herpes, herpes simplex virus, varicella-zoster virus, herpes zoster, recurrent aphthous ulcers, gingivectomy, periodontology, hyposialia, xerostomia, sjőgren's syndrome, substitution, stimulation, teriparatide, osteonecrosis, jaw bone, biologic therapy, belimumab, abatacept, epratuzumab, clinical study, active substance, medical device, local therapy, systemic therapy, Dentistry, RK1-715

وصف الملف: electronic resource

Relation: https://cspzl.dent.cz/en/artkey/sto-201503-0005_new-pharmacotherapeutic-posssibilities-in-contemporary-dentistry.php; https://doaj.org/toc/1213-0613; https://doaj.org/toc/1805-4471

URL الوصول: https://doaj.org/article/8653660e0ad8408faf4694109c09a007